We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Radical treatment

10 September 2008 By Pierre Briancon

The French pharmaceuticals company s largest shareholders, Total and L Oreal, have taken action in response to the long share price slide that followed the botched merger with Aventis. CEO Gerard Le Fur is out. But the chairman, JeanFrancois Dehecq, should go as well.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)